Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

Therapy for adult acute lymphoblastic leukemia (ALL) with multiagent cytotoxic chemotherapy has not been as successful as that for pediatric patients. The advent of targeted monoclonal antibodies against common cell surface antigens (i.e. CD19, CD20, and CD22) has resulted in improved outcomes witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Savoy, J. Michael, Welch, Mary Alma, Nasnas, Patrice E., Kantarjian, Hagop, Jabbour, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992772/
https://www.ncbi.nlm.nih.gov/pubmed/33815734
http://dx.doi.org/10.1177/2040620718812013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992772/
https://www.ncbi.nlm.nih.gov/pubmed/33815734
http://dx.doi.org/10.1177/2040620718812013

Ejemplares similares